Streetbeat News

Stock Prices

AVBP

ArriVent BioPharma shares are indicating a price of $20.50 based on the trading volume of 270,000 shares.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 4:10 pm

DOW

JP Morgan analyst Jeffrey Zekauskas downgraded Dow (NYSE:DOW) from Overweight to Neutral and set a new price target of $55.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 4:08 pm

Z

JP Morgan analyst Dae Lee has maintained an Overweight rating on Zillow Group (NASDAQ:Z) and increased the price target from $46 to $65, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 4:04 pm

HAO

Shares of Haoxi Health Technology were halted due to a circuit breaker after surging 55%. The halt is a mechanism to prevent excessive volatility in the stock market.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 4:04 pm

XRX

JP Morgan analyst Samik Chatterjee has maintained an Underweight rating on Xerox Holdings (NASDAQ:XRX) but increased the price target from $16 to $18.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 4:02 pm

GATX

GATX Corporation has announced an increase in its quarterly dividend from $0.55 to $0.58 per share, signaling confidence in its financial stability and commitment to returning value to shareholders.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 4:02 pm

PYPL

The article provides an industry comparison of PayPal Holdings (NASDAQ:PYPL) against its competitors in the Financial Services industry. It highlights PayPal's financial metrics such as P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth, comparing them to industry averages and top peers. PayPal shows favorable growth potential with a lower P/E ratio than the industry average, potential undervaluation with a lower P/B ratio, and strong profitability with higher EBITDA and gross profit. However, it has a lower ROE and revenue growth compared to the industry, suggesting inefficiencies and limited expansion opportunities.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 4:02 pm

IBM

IBM (NYSE:IBM) is analyzed in comparison to its IT Services industry competitors, revealing its strong market positioning and growth potential. Key financial metrics such as P/E, P/B, P/S, ROE, EBITDA, gross profit, and revenue growth are examined, with IBM showing favorable growth potential, possible undervaluation, efficient equity use, robust profitability, and market outperformance. IBM's debt-to-equity ratio suggests a balanced financial structure.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 4:01 pm

PROV

Provident Financial Holdings (NASDAQ:PROV) is scheduled to release its quarterly earnings report on Monday, 2024-01-29, with analysts expecting an EPS of $0.25. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, the company's stock price has been sensitive to earnings performance and guidance. Last quarter, PROV missed EPS estimates by $0.03, resulting in a 3.96% share price drop the following day. Over the last year, PROV shares have slightly increased by 0.62%, with the stock currently trading at $14.5.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 4:01 pm

HITI

High Tide (NASDAQ:HITI) is expected to release its quarterly earnings report on January 29, 2024, with an estimated EPS of $-0.03. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, the company's stock price has been sensitive to earnings performance and guidance. Last quarter, High Tide missed EPS estimates by $0.00, resulting in a 13.78% share price drop the following day. Over the last 52 weeks, HITI shares have increased by 8.38%, trading at $1.89 as of January 25.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 4:01 pm